We are live on
!
Find out more
SC
Sculptor Capital Portfolio holdings
AUM
$12.3B
1-Year Est. Return
40.26%
This Fund
S&P 500
This Quarter
Est. Return
+5.43%
1 Year Est. Return
+40.26%
3 Year Est. Return
+130.39%
5 Year Est. Return
+159.57%
10 Year Est. Return
+426.86%
AUM
$5.04B
AUM Growth
+$575M
(+13%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
44.99%
Holding
626
New
77
Increased
50
Reduced
98
Closed
179
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seadrill
SDRL
|
+$179M |
| 2 |
VMW
VMware, Inc
VMW
|
+$94.5M |
| 3 |
UnitedHealth
UNH
|
+$74.9M |
| 4 |
First Horizon
FHN
|
+$59.8M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$58.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$122M |
| 2 |
Workday
WDAY
|
+$76.2M |
| 3 |
Ferguson
FERG
|
+$58.7M |
| 4 |
PCGU
PG&E Corporation
PCGU
|
+$54.9M |
| 5 |
Microsoft
MSFT
|
+$49.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.74% |
| 2 | Communication Services | 21.02% |
| 3 | Technology | 16.97% |
| 4 | Healthcare | 6.21% |
| 5 | Financials | 5.16% |
Similar funds
PI
RA
JCAM
JF
QCM
WRCM
Sculptor Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Sculptor Capital held 626 positions worth $5.04B, up 13% from $4.46B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Sculptor Capital withdrew a net $758M in Q2 2023, closing 179 positions and reducing 98 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $122M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 40% of assets, up from 30% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Sculptor Capital opened a new position in Seadrill worth $199M.
- Sculptor Capital's largest Q2 2023 buy was Seadrill: 4,829,562 shares worth $199M.
- Sculptor Capital added most to VMware, Inc in Q2 2023, an estimated $94.5M increase.
- Sculptor Capital's biggest Q2 2023 reduction was Workday, cutting an estimated $76.2M.
- Sculptor Capital fully exited Thermo Fisher Scientific in Q2 2023, selling an estimated $122M.
- Sculptor Capital's ten largest holdings make up 45% of its $5.04B portfolio in Q2 2023.
- Sculptor Capital opened 77 new positions and closed 179 in Q2 2023.
- Sculptor Capital's portfolio value rose 13% quarter-over-quarter to $5.04B.
Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.